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Abstract
Background: We have previously reported the case of an immunocompetent female patient with a primary
cutaneous CD30+ anaplastic large-cell lymphoma (PCALCL) located on her upper right eyelid characterized by the
presence of a concurrent active infection by C. pneumoniae and Human herpesvirus 8 (HHV8). This finding
suggested for the first time a possible association of C. pneumoniae and/or HHV8 infection, or both together, with
PCALCL pathogenesis in non-immunocompromised and HIV-negative subjects. The subsequent course of the same
patient’s medical history is herein reported.
Findings: During the 4 years following the surgical excision of the first PCALCL, the patient developed five further
skin lesions located at different anatomical sites, all histologically proven as PCALCLs. The patient underwent several
cycles of doxycycline as prophylaxis against Chlamydia. Skin presence of Chlamydia spp and HHV8 was investigated
in all recurrences as well as in routine control blood samples. Amplification fragments corresponding to Chlamydia
were found in all skin tissues analysed except one (4/5; 80 %), whereas it was not detected in any of the peripheral
blood mononuclear cell samples. Conversely, HHV8 was detected in 2/5 (40 %) of the skin biopsies, including the
sample negative for Chlamydia, but in all the blood samples analysed.
Conclusions: These findings further support the hypothesis of a potential role of C. pneumoniae and HHV8
infection in the development and course of the described cutaneous lymphoma. A reciprocally promoting
interaction between the two pathogens may be supposed to be relevant for PCALC occurrence and relapse.
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Introduction
Several infectious triggers have been associated with the
development of cutaneous lymphomas. However, the ac-
tual implication of infectious agents in the pathogenesis of
such disorders remains controversial [1–5]. In a previous
report [6], we reported the case of an immunocompetent
female patient with a primary cutaneous CD30+ anaplastic
large-cell lymphoma (PCALCL) of her upper right eyelid,
characterized by the presence of a concurrent active infec-
tion by C. pneumoniae and Human herpesvirus 8 (HHV8).
This finding suggested that these microorganisms could
be involved in the development of the PCALCL by recip-
rocally potentiating their pathogenic potential.
Here we report the subsequent course of the same pa-
tient’s medical history, with particular regard to
PCALCL recurrences and concomitant search for C.
pneumoniae and HHV8.
Case report
The patient, a 68-year-old woman, during the 4 years
following the surgical excision of the first PCALCL on
her upper right eyelid (July 2011), which microbiolgical
and molecular examination previously detected C. pneu-
moniae and HHV-8, presented at our Dermatology
outpatient Unit for the sequential development of five
further skin lesions (Table 1). For all these lesions, histo-
pathological and immunohistochemical analyses revealed
the diagnosis of cutaneous CD30+ anaplastic large cell
lymphoma, like the first excised tumor [6].
More in detail, in September 2012 the patient presented
due to the rapid onset of an erythematous, itching plaque,
with a mamillated surface, 12 × 8 mm in diameter, on the
right side of the posterior surface of her neck (Fig. 1a).
After histological confirmation of a biopsy specimen, the
lesion was treated with daily application of topical cortico-
steroid and oral doxycycline 200 mg/day for 3 weeks be-
cause of a possible relapse by C. pneunoniae. Two months
later, the plaque had resolved leaving a hyperchromic
macule. Then, the patient underwent three further 2-week
cycles of doxycycline 200 mg/day as prophylaxis against
Chlamydia, at 6–8 month intervals.
In June 2013, the woman presented with both a pink-
ish dome-shaped plaque on her left hemiabdomen
(Fig. 1b) and a reddish-brown nodule, with well-defined
borders, covered with crust, located on her left commis-
sure of the lips (Fig. 1c). The patient referred the sudden
and almost concomitant onset of both lesions, which
were surgically excised.
Table 1 PCR results in skin specimens and PBMC from the patient with C. pneumoniae and HHV-8 coinfection
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In June 2014, an erythematous plaque, 12 × 10 mm in
diameter was rapidly developed on the patient right
labia maiora. The lesion was submitted to complete
surgical excision.
In December 2014, the patient presented with a pro-
gressively enlarging reddish, finely scaly plaque, located
on her upper left eyelid (Fig. 1d). A complete surgical
excision of the lesion was performed.
It is worthy of note, that the patient referred that all
the PCALCL recurrences occurred in close conjunction
with stressful events or periods in her life.
Over the entire lapse of time described, periodical clin-
ical and instrumental follow up of the patient, including
positron emission tomography/computed tomography
scan of the body, bone marrow biopsy, complete blood
count with differential, and blood chemistry including
lactate dehydrogenase, showed no evidence of extracuta-
neous involvement.
In June 2015, the patient addressed the hematologic
unit of another hospital and was treated with gemcita-
bine 1000 mg/m2 per day, three administrations per
month for a total of three consecutive cycles, due to the
previous recurrences of skin lymphomas. The treatment
was well tolerated by the patient. In the same period, the
patient started a prophylactic treatment with isoniazid,
as a latent tuberculosis infection was supposed based on
both QuantiFERON test positivity and a computerized
tomography scan of the chest.
Up to date, no further skin lesions appeared.
Methods and results
Due to the microbiological findings concerning the first
PCALCL lesion, skin presence of Chlamydia spp and
HHV8 was investigated in all subsequent recurrences,
after receiving informed consent from the patient. Both
pathogens were searched in routine control blood sam-
ples as well. Approval by the institutional review board
of our Hospital was not required for the present study,
as materials were not collected specifically for this study,
and were completely de-identified.
C. pneumoniae was searched in cutaneous biopsies
and in peripheral blood mononuclear cells (PBMCs) iso-
lated by density gradient from peripheral blood (Fycoll-
paque plus, GE Healthcare Europe GmbH, Milan, Italy)
as previously described [6, 7]. DNA was extracted and
processed as previously described [7, 8], and assayed by
PCR. Molecular analyses included nested-PCR using pri-
mer sets targeting 16S rRNA, outer membrane protein
(ompA/MOMP), and HsP-60 genomic regions of C. psit-
taci, C. pneumoniae, and C. trachomatis [7].
In parallel, the same specimens were also used for
HHV8 search, performed by two different PCRs specific-
ally designed in the ORF50 and ORF26 genes of HHV8
genome [8]. The analysis of two different genes was
undertaken to avoid the risk of false positive/negative re-
sults connected with a single gene detection.
The laboratory results are summarized in Table 1.
Amplification fragments corresponding to Chlamydia
were found in all skin tissues analysed except one (4/
5; 80 %). On the contrary, it was not detected in any
of the PBMC samples. Conversely, HHV8 was de-
tected in 2/5 (40 %) of the skin biopsies, including the
sample negative for Chlamydia, but in all the blood
samples analysed.
Discussion
Primary cutaneous T-cell lymphoma (CTCL) are defined
as lymphomas occurring at the skin level, with no
Fig. 1 Clinical features of PCALCL recurrences located at a) posterior surface of the patient’s neck, b) left hemiabdomen, c) left commissure of the
lips, d) upper left eyelid
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evidence of extracutaneous disease at the time of diag-
nosis [9]. In particular, primary cutaneous CD30+ T-
cell lymphoproliferative disorders are the second most
common group of CTCLs and include PCALCL and
lymphomatoid papulosis [10]. PCALCL occur predom-
inantly in the adult/elderly population, where show a
male predominance. They are characterized by solitary
or localized nodules, tumors, or papules that frequently
become ulcerated, and histologically present diffuse
sheets of large tumor cells with an anaplastic, pleo-
morphic or immunoblastic cytomorphology, largely ex-
pressing (>75 %) CD30. Partial or complete regression
may occur, but skin relapses can be observed, as in the
case reported. The prognosis of PCALCL is good, with
5-year survival rates between 76 and 96 % [11].
The aetiology of CTCLs is still unclear, although a role
for superantigenic activation of T cells leading to accu-
mulation of skin-homing T cells has been suggested [12].
Notably, infectious agents have been suggested to have a
role in the etiology of other lymphomas, including some
non Hodgkin lymphomas, such as gastric and ocular
adnexa MALT lymphomas [13–15]. In fact, some vi-
ruses can transform lymphocytes as well as a chronic
immune stimulus, caused by persistent viral or bacterial
infection, can be associated with the selection of
lymphocytic clones potentially resulting in lymphoma
development [16].
In the described patient, the initial detection of both
C. pneumoniae and HHV8 in the first occurrence of
PCALCL on her upper right eyelid, suggested a potential
pathogenetic involvement of such agents [6].
Accumulating evidences suggest that Chlamydia spp.
may play a role in oncogenesis, due to its tendency to
cause persistent infections and chronic antigenic stimu-
lation [17]. In particular, C. pneumoniae has been shown
to be present in some CTCL and to induce the expan-
sion of C. pneumoniae-specific T cells throughout the
release of Sézary T cell-activating factor (SAF) [18].
Moreover, C. pneumoniae eradication with doxycycline
has been reported to result in lymphoma regression in
about a half of patients [19]. However, its implication in
the pathogenesis of skin lymphomas remains unclear.
On the other hand, herpesviruses have been hypothe-
sized as possible triggers of CTCLs [20, 21]. Among
these, HHV8 seems particularly interesting, due to its
oncogenic activity: it is causally related to Kaposi’s sar-
coma (KS), Multicentric Castleman’s Disease (MCD),
and Primary Effusion Lymphomas (PEL), and associated
to other lymphoproliferative disorders occurring primar-
ily in immunosuppresed patients [22, 23]. Interestingly,
we recently observed a high prevalence of HHV8 in skin
biopsies from angiomatous lesions [24], occurring preva-
lently in immunosuppressed individuals, suggesting that
this virus might be involved in the development of skin
lesions other than KS. Furthermore, several HHV8 genes
can trigger cell transformation, being directly responsible
for its oncogenic potential [23].
The results reported herein further support the hy-
pothesis of a potential role of C. pneumoniae and/or
HHV8 infection, or both together, in the development
and course of the described cutaneous lymphoma. In-
deed, the presence of C. pneumoniae was revealed in 4/5
skin PCALCL recurrences, whereas HHV8 DNA was de-
tectable in two cutaneous recurrences only, including
the one in which Chlamydia was not detected. On the
other hand, the presence of HHV8 was a constant find-
ing in blood PBMCs, whereas C. pneumoniae was no
longer detectable in PBMCs after the antibiotic courses
suggesting bacterial eradication from this compartment
following doxycycline therapy.
The differences in pathogens’ presence in blood and
tissue specimens might reflect the peculiar biological be-
havior of the two pathogens. In fact, similarly to other
human herpesviruses, HHV8 establishes lifetime persist-
ence in infected individuals, where 50–100 copies of
virus genome per infected cell can be found in periph-
eral blood lymphocytes/monocytes, which represent the
virus reservoir [25, 26]. Consequently, the virus load at tis-
sue level might be lower than in blood, unless the virus is
actively replicating in tissues because of reactivation.
By contrast, the reservoir of Chlamydia during per-
sistence is not fully elucidated, although it has been
suggested that the gastrointestinal tract might be in-
volved [27]. Moreover, recurrent chlamydial manifesta-
tions may result from either repeated infections or
persistence of the organism after unresolved but often
host damaging infections, and it is not easy to differen-
tiate between persistent infection and reinfection [28].
Accordingly, in our clinical specimens, Chlamydia ap-
peared concentrated in the skin tissue, rather than in
blood, where it was apparently eradicated, suggesting
that its eventual presence was discontinuous and that
antibiotic treatment maintained Chlamydia load un-
detectable in the blood.
Epidemiological studies have connected human her-
pesviruses and Chlamydia in several diseases, including
endometritis, salpingitis, cervical cancer, chronic fatigue
syndrome and multiple sclerosis [29–35]. Moreover, it
has been shown that co-infection with HSV-1, HSV-2,
HCMV or HHV-6 influences C. pneumoniae replication
[36], promoting chlamydial persistence and increasing
viral uptake. Interestingly, it was also reported that C.
trachomatis induced reactivation of chromosomally inte-
grated HHV6, and that in coinfected women low virus
titers correlated with high C. trachomatis load and vice
versa, demonstrating a potentially significant interaction
of these pathogens in blood cells and in the cervix of in-
fected patients [36]. Moreover, HHV6, CMV and HSV-1
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have been reported to induce chlamydial persistence by
inducing oxidative stress [36].
Our findings suggest that a similar interaction might
occur also between Chlamydia and HHV8. The presence
of HHV8 might support the persistence or the reinfec-
tion of C. pneumoniae in the skin, where it might induce
tissue damage in spite of its apparent eradication in
peripheral blood. At the same time, the presence of
Chlamydia might facilitate reactivation of HHV8, fi-
nally resulting in the development of PCALCL recur-
rences. Interestingly, the appearance of recurrences
following periods of psycho-emotional stress, as in the
case reported, highlights the role of impairment of im-
mune surveillance, and further support the hypothesis
of a role of endogenous reactivation of the detected
pathogens in the observed recurrent diseases.
A limitation of the present study is represented by the
absence of transcriptional data, which would have clari-
fied the replicative status of both pathogens in the differ-
ent clinical specimens, but unfortunately the fresh
specimens were not available for this analysis.
Furthermore, future mechanistic studies are needed to
understand the interaction between these two pathogens
inside a coinfected cell. No studies are in fact reported
in the literature about the possible mutual interaction
between HHV8 and C. pneumoniae.
Based on our observations, it would be interesting to
analyze in vitro their mutual behavior in different cell
types (i.e. lymphocytes/monocytes or epithelial cells)
coinfected by both pathogens.
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